• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺相关病毒介导的β-己糖胺酶表达可防止桑德霍夫小鼠脑神经元丢失。

Adeno-associated virus-mediated expression of β-hexosaminidase prevents neuronal loss in the Sandhoff mouse brain.

机构信息

Department of Medicine, University of Cambridge, Level 5 Addenbrooke's Hospital, Box 157, Hills Road, Cambridge CB2 0QQ, UK.

出版信息

Hum Mol Genet. 2011 Nov 15;20(22):4371-80. doi: 10.1093/hmg/ddr364. Epub 2011 Aug 18.

DOI:10.1093/hmg/ddr364
PMID:21852247
Abstract

Sandhoff disease, a GM2 gangliosidosis caused by a deficiency in β-hexosaminidase, is characterized by progressive neurodegeneration. Although loss of neurons in association with lysosomal storage of glycosphingolipids occurs in patients with this disease, the molecular pathways that lead to the accompanying neurological defects are unclear. Using an authentic murine model of GM2 gangliosidosis, we examined the pattern of neuronal loss in the central nervous system and investigated the effects of gene transfer using recombinant adeno-associated viral vectors expressing β-hexosaminidase subunits (rAAV2/1-Hex). In 4-month-old Sandhoff mice with neurological deficits, cells staining positively for the apoptotic signature in the TUNEL reaction were found in the ventroposterior medial and ventroposterior lateral (VPM/VPL) nuclei of the thalamus. There was progressive loss of neuronal density in this region with age. Comparable loss of neuronal density was identified in the lateral vestibular nucleus of the brainstem and a small but statistically significant loss was present in the ventral spinal cord. Loss of neurons was not detected in other regions that were analysed. Administration of rAAV2/1-Hex into the brain of Sandhoff mice prevented the decline in neuronal density in the VPM/VPL. Preservation of neurons in the VPM/VPL was variable at the humane endpoint in treated animals, but correlated directly with increased lifespan. Loss of neurons was localized to only a few regions in the Sandhoff brain and was prevented by rAAV-mediated transfer of β-hexosaminidase gene function at considerable distances from the site of vector administration.

摘要

沙夫病(Sandhoff disease)是一种由β-己糖胺酶缺乏引起的 GM2 神经节苷脂贮积症,其特征是进行性神经退行性变。虽然这种疾病患者的神经元丧失与溶酶体糖脂储存有关,但导致伴随神经缺陷的分子途径尚不清楚。我们使用 GM2 神经节苷脂贮积症的真实鼠模型,研究了中枢神经系统中神经元丧失的模式,并研究了使用表达β-己糖胺酶亚基的重组腺相关病毒载体(rAAV2/1-Hex)进行基因转移的效果。在有神经功能缺损的 4 月龄沙夫病鼠中,在丘脑的腹后内侧核和腹后外侧核(VPM/VPL)中发现了 TUNEL 反应呈阳性的凋亡标记细胞。随着年龄的增长,该区域的神经元密度逐渐丧失。在脑干外侧前庭核中也发现了类似的神经元密度丧失,并且在脊髓腹侧也存在统计学上显著的小量丧失。在分析的其他区域未发现神经元丧失。将 rAAV2/1-Hex 注入沙夫病鼠的脑内可防止 VPM/VPL 中神经元密度的下降。在治疗动物的人道终点时,VPM/VPL 中神经元的保存情况是可变的,但与寿命延长直接相关。在沙夫病鼠的大脑中,神经元丧失仅局限于少数几个区域,并且 rAAV 介导的β-己糖胺酶基因功能转移可在距载体给药部位相当远的距离处预防神经元丧失。

相似文献

1
Adeno-associated virus-mediated expression of β-hexosaminidase prevents neuronal loss in the Sandhoff mouse brain.腺相关病毒介导的β-己糖胺酶表达可防止桑德霍夫小鼠脑神经元丢失。
Hum Mol Genet. 2011 Nov 15;20(22):4371-80. doi: 10.1093/hmg/ddr364. Epub 2011 Aug 18.
2
Systemic Gene Transfer of a Hexosaminidase Variant Using an scAAV9.47 Vector Corrects GM2 Gangliosidosis in Sandhoff Mice.使用scAAV9.47载体进行己糖胺酶变体的全身基因转移可纠正桑德霍夫小鼠的GM2神经节苷脂病。
Hum Gene Ther. 2016 Jul;27(7):497-508. doi: 10.1089/hum.2016.015.
3
Metabolic correction in microglia derived from Sandhoff disease model mice.源自桑德霍夫病模型小鼠的小胶质细胞中的代谢校正
J Neurochem. 2005 Sep;94(6):1631-8. doi: 10.1111/j.1471-4159.2005.03317.x. Epub 2005 Aug 10.
4
Reversion of the biochemical defects in murine embryonic Sandhoff neurons using a bicistronic lentiviral vector encoding hexosaminidase alpha and beta.使用编码己糖胺酶α和β的双顺反子慢病毒载体逆转小鼠胚胎桑德霍夫神经元中的生化缺陷。
J Neurochem. 2006 Mar;96(6):1572-9. doi: 10.1111/j.1471-4159.2006.03665.x. Epub 2006 Jan 25.
5
Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy.尽管对颅内基因治疗具有免疫性,猫桑德霍夫病仍有治疗反应。
Mol Ther. 2013 Jul;21(7):1306-15. doi: 10.1038/mt.2013.86. Epub 2013 May 21.
6
Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.通过将人溶酶体β-己糖胺酶β亚基基因转移至源自桑德霍夫病模型小鼠的成纤维细胞系来消除GM2神经节苷脂的低效性。
Biol Pharm Bull. 2006 Aug;29(8):1564-9. doi: 10.1248/bpb.29.1564.
7
Reversibility of neuropathology in Tay-Sachs-related diseases.泰萨氏症相关疾病的神经病理学可逆性。
Hum Mol Genet. 2014 Feb 1;23(3):730-48. doi: 10.1093/hmg/ddt459. Epub 2013 Sep 20.
8
Direct Intracranial Injection of AAVrh8 Encoding Monkey β-N-Acetylhexosaminidase Causes Neurotoxicity in the Primate Brain.直接向颅内注射编码猴β-N-乙酰氨基己糖苷酶的AAVrh8会导致灵长类动物大脑出现神经毒性。
Hum Gene Ther. 2017 Jun;28(6):510-522. doi: 10.1089/hum.2016.109. Epub 2017 Jan 26.
9
Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff Mice.单次全身给药的双方向 AAV 载体在桑德霍夫小鼠中的显著治疗效果。
Mol Ther. 2020 Oct 7;28(10):2150-2160. doi: 10.1016/j.ymthe.2020.06.021. Epub 2020 Jun 19.
10
Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease.在桑德霍夫病猫模型中进行颅内基因治疗后中枢神经系统疾病的广泛纠正。
Gene Ther. 2015 Feb;22(2):181-9. doi: 10.1038/gt.2014.108. Epub 2014 Dec 4.

引用本文的文献

1
Microglia-neuron crosstalk through Hex-GM2-MGL2 maintains brain homeostasis.通过己糖-GM2-巨噬细胞半乳糖凝集素2的小胶质细胞-神经元串扰维持脑内稳态。
Nature. 2025 Aug 6. doi: 10.1038/s41586-025-09477-y.
2
Advances in Diagnosis, Pathological Mechanisms, Clinical Impact, and Future Therapeutic Perspectives in Tay-Sachs Disease.泰-萨克斯病的诊断进展、病理机制、临床影响及未来治疗前景
Neurol Int. 2025 Jun 25;17(7):98. doi: 10.3390/neurolint17070098.
3
Treating late-onset Tay Sachs disease: Brain delivery with a dual trojan horse protein.治疗晚发性泰-萨克斯病:利用双“特洛伊木马”蛋白实现脑部递送
Mol Ther Methods Clin Dev. 2024 Jul 17;32(3):101300. doi: 10.1016/j.omtm.2024.101300. eCollection 2024 Sep 12.
4
Exploring Pro-Inflammatory Immunological Mediators: Unraveling the Mechanisms of Neuroinflammation in Lysosomal Storage Diseases.探索促炎免疫介质:揭示溶酶体贮积病中的神经炎症机制
Biomedicines. 2023 Apr 1;11(4):1067. doi: 10.3390/biomedicines11041067.
5
Gene Therapy of Sphingolipid Metabolic Disorders.鞘脂代谢障碍的基因治疗。
Int J Mol Sci. 2023 Feb 11;24(4):3627. doi: 10.3390/ijms24043627.
6
Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis.基因/细胞联合治疗策略在GM2神经节苷脂沉积症小鼠模型中的治疗优势
Mol Ther Methods Clin Dev. 2022 Mar 16;25:170-189. doi: 10.1016/j.omtm.2022.03.011. eCollection 2022 Jun 9.
7
White Matter Pathology as a Barrier to Gangliosidosis Gene Therapy.白质病理学作为神经节苷脂贮积症基因治疗的障碍
Front Cell Neurosci. 2021 Aug 12;15:682106. doi: 10.3389/fncel.2021.682106. eCollection 2021.
8
Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development.基因治疗溶酶体贮积症:正在进行的研究和临床开发。
Biomolecules. 2021 Apr 20;11(4):611. doi: 10.3390/biom11040611.
9
Decrease in Myelin-Associated Lipids Precedes Neuronal Loss and Glial Activation in the CNS of the Sandhoff Mouse as Determined by Metabolomics.代谢组学研究表明,在桑德霍夫小鼠的中枢神经系统中,髓鞘相关脂质的减少先于神经元丢失和胶质细胞激活。
Metabolites. 2020 Dec 30;11(1):18. doi: 10.3390/metabo11010018.
10
Dual Purpose Vectors for Rare Neurological Diseases.用于罕见神经疾病的双功能载体。
Mol Ther. 2020 Oct 7;28(10):2104-2105. doi: 10.1016/j.ymthe.2020.09.017. Epub 2020 Sep 18.